Identification and Determination of Impurities in a New Therapeutic Agent for Fatty Liver Disease

Table 1

MS fragment pathways and quantitative ions of IMM and impurity V.

No	Code	MRM (m/z)	MS fragment pathways
1	IMM	460.1 ⟶ 341
2	Impurity V	476.1 ⟶ 373.2